FBIO•benzinga•
Fortress Biotech Earnings Perspective: Return On Capital Employed
Summary
Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q2 sales of $18.89 million. Earnings fell to a loss of $53.93 million, resulting in a 9.0% decrease from last quarter.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 8, 2022 by benzinga